Literature DB >> 21087673

D2 receptor genotype and striatal dopamine signaling predict motor cortical activity and behavior in humans.

Leonardo Fazio1, Giuseppe Blasi, Paolo Taurisano, Apostolos Papazacharias, Raffaella Romano, Barbara Gelao, Gianluca Ursini, Tiziana Quarto, Luciana Lo Bianco, Annabella Di Giorgio, Marina Mancini, Teresa Popolizio, Giuseppe Rubini, Alessandro Bertolino.   

Abstract

OBJECTIVE: Pre-synaptic D2 receptors regulate striatal dopamine release and DAT activity, key factors for modulation of motor pathways. A functional SNP of DRD2 (rs1076560 G>T) is associated with alternative splicing such that the relative expression of D2S (mainly pre-synaptic) vs. D2L (mainly post-synaptic) receptor isoforms is decreased in subjects with the T allele with a putative increase of striatal dopamine levels. To evaluate how DRD2 genotype and striatal dopamine signaling predict motor cortical activity and behavior in humans, we have investigated the association of rs1076560 with BOLD fMRI activity during a motor task. To further evaluate the relationship of this circuitry with dopamine signaling, we also explored the correlation between genotype based differences in motor brain activity and pre-synaptic striatal DAT binding measured with [(123)I] FP-CIT SPECT.
METHODS: Fifty healthy subjects, genotyped for DRD2 rs1076560 were studied with BOLD-fMRI at 3T while performing a visually paced motor task with their right hand; eleven of these subjects also underwent [(123)I]FP-CIT SPECT. SPM5 random-effects models were used for statistical analyses.
RESULTS: Subjects carrying the T allele had greater BOLD responses in left basal ganglia, thalamus, supplementary motor area, and primary motor cortex, whose activity was also negatively correlated with reaction time at the task. Moreover, left striatal DAT binding and activity of left supplementary motor area were negatively correlated.
INTERPRETATION: The present results suggest that DRD2 genetic variation was associated with focusing of responses in the whole motor network, in which activity of predictable nodes was correlated with reaction time and with striatal pre-synaptic dopamine signaling. Our results in humans may help shed light on genetic risk for neurobiological mechanisms involved in the pathophysiology of disorders with dysregulation of striatal dopamine like Parkinson's disease.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21087673     DOI: 10.1016/j.neuroimage.2010.11.034

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  19 in total

1.  An iterative two-threshold analysis for single-subject functional MRI of the human brain.

Authors:  Tibor Auer; Renate Schweizer; Jens Frahm
Journal:  Eur Radiol       Date:  2011-06-28       Impact factor: 5.315

2.  Building a FP-CIT SPECT Brain Template Using a Posterization Approach.

Authors:  D Salas-Gonzalez; Juan M Górriz; Javier Ramírez; Ignacio A Illán; Pablo Padilla; Francisco J Martínez-Murcia; Elmar W Lang
Journal:  Neuroinformatics       Date:  2015-10

3.  DRD2 Genotype-Based Variants Modulates D2 Receptor Distribution in Ventral Striatum.

Authors:  Mikaeel Valli; Sang Soo Cho; Mario Masellis; Robert Chen; Pablo Rusjan; Jinhee Kim; Yuko Koshimori; Alexander Mihaescu; Antonio P Strafella
Journal:  Mol Neurobiol       Date:  2019-03-08       Impact factor: 5.590

4.  Morphological changes in gray matter volume correlate with catechol-O-methyl transferase gene Val158Met polymorphism in first-episode treatment-naïve patients with schizophrenia.

Authors:  Ming-Li Li; Bo Xiang; Yin-Fei Li; Xun Hu; Qiang Wang; Wan-Jun Guo; Wei Lei; Chao-Hua Huang; Lian-Sheng Zhao; Na Li; Hong-Yan Ren; Hui-Yao Wang; Xiao-Hong Ma; Wei Deng; Tao Li
Journal:  Neurosci Bull       Date:  2015-01-06       Impact factor: 5.203

5.  Altered regional brain volumes in elderly carriers of a risk variant for drug abuse in the dopamine D2 receptor gene (DRD2).

Authors:  Florence F Roussotte; Neda Jahanshad; Derrek P Hibar; Paul M Thompson
Journal:  Brain Imaging Behav       Date:  2015-06       Impact factor: 3.978

6.  Association between AVPR1A, DRD2, and ASPM and endophenotypes of communication disorders.

Authors:  Catherine M Stein; Barbara Truitt; Fenghua Deng; Allison Avrich Ciesla; Feiyou Qiu; Peronne Joseph; Rekha Raghavendra; Jeremy Fondran; Robert P Igo; Jessica Tag; Lisa Freebairn; H Gerry Taylor; Barbara A Lewis; Sudha K Iyengar
Journal:  Psychiatr Genet       Date:  2014-10       Impact factor: 2.458

7.  DRD2 genotype predicts prefrontal activity during working memory after stimulation of D2 receptors with bromocriptine.

Authors:  Barbara Gelao; Leonardo Fazio; Pierluigi Selvaggi; Annabella Di Giorgio; Paolo Taurisano; Tiziana Quarto; Raffaella Romano; Annamaria Porcelli; Marina Mancini; Rita Masellis; Gianluca Ursini; Giuseppe De Simeis; Grazia Caforio; Laura Ferranti; Luciana Lo Bianco; Antonio Rampino; Orlando Todarello; Teresa Popolizio; Giuseppe Blasi; Alessandro Bertolino
Journal:  Psychopharmacology (Berl)       Date:  2014-01-15       Impact factor: 4.530

8.  The dopamine receptor D2 (DRD2) SNP rs1076560 is associated with opioid addiction.

Authors:  Toni-Kim Clarke; Amy R D Weiss; Thomas N Ferarro; Kyle M Kampman; Charles A Dackis; Helen M Pettinati; Charles P O'brien; David W Oslin; Falk W Lohoff; Wade H Berrettini
Journal:  Ann Hum Genet       Date:  2013-11-25       Impact factor: 1.670

9.  Catechol-o-methyl transferase (COMT) val158met polymorphism and adolescent cortical development in patients with childhood-onset schizophrenia, their non-psychotic siblings, and healthy controls.

Authors:  Armin Raznahan; Deanna Greenstein; Yohan Lee; Robert Long; Liv Clasen; Pete Gochman; Anjene Addington; Jay N Giedd; Judith L Rapoport; Nitin Gogtay
Journal:  Neuroimage       Date:  2011-05-15       Impact factor: 6.556

10.  HIV-related cognitive impairment shows bi-directional association with dopamine receptor DRD1 and DRD2 polymorphisms in substance-dependent and substance-independent populations.

Authors:  Michelle M Jacobs; Jacinta Murray; Desiree A Byrd; Yasmin L Hurd; Susan Morgello
Journal:  J Neurovirol       Date:  2013-10       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.